Trichomegaly and other external eye side effects associated with epidermal growth factor

Frederick (Fritz) Fraunfelder, Frederick W. Fraunfelder

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Context/objective: To report an association between epithelial growth factor receptor (EGFR) inhibitors and ocular side effects. Materials and methods: Collection of spontaneous reports at the National Registry of Drug-Induced Ocular Side Effects (Casey Eye Institute, Portland, Oregon) in conjunction with a literature review of EGFR inhibitors associated with ocular adverse drug reactions (ADR). Results: EGFR inhibitors are associated with conjunctivitis, meibomitis, dry eyes, periocular skin changes and trichomegaly. EGFR inhibitors may also cause superficial punctate corneal changes and corneal erosions. Discussion: This is the first overview of all known ocular side effects associated with the use of marketed EGFR inhibitors. This is also the first effort for this class of drugs using the World Health Organization Classification as to causality. Conclusion: Ophthalmologists should be aware of possible adverse ocular side effects from EGFR inhibitors and treat based on the type of ADR encountered. All ocular side effects noted are fully reversible upon discontinuation of the drug.

Original languageEnglish (US)
Pages (from-to)195-197
Number of pages3
JournalCutaneous and Ocular Toxicology
Volume31
Issue number3
DOIs
StatePublished - Sep 2012

Fingerprint

Growth Factor Receptors
Epidermal Growth Factor
Pharmaceutical Preparations
Drug-Related Side Effects and Adverse Reactions
Conjunctivitis
Erosion
Skin
Health
Causality
Registries

Keywords

  • Conjunctivitis
  • Dry eyes
  • Meibomitis
  • Toxicity
  • Trichomegaly

ASJC Scopus subject areas

  • Toxicology

Cite this

Trichomegaly and other external eye side effects associated with epidermal growth factor. / Fraunfelder, Frederick (Fritz); Fraunfelder, Frederick W.

In: Cutaneous and Ocular Toxicology, Vol. 31, No. 3, 09.2012, p. 195-197.

Research output: Contribution to journalArticle

@article{88a25c3d9c0d4bee9b528633225c78a4,
title = "Trichomegaly and other external eye side effects associated with epidermal growth factor",
abstract = "Context/objective: To report an association between epithelial growth factor receptor (EGFR) inhibitors and ocular side effects. Materials and methods: Collection of spontaneous reports at the National Registry of Drug-Induced Ocular Side Effects (Casey Eye Institute, Portland, Oregon) in conjunction with a literature review of EGFR inhibitors associated with ocular adverse drug reactions (ADR). Results: EGFR inhibitors are associated with conjunctivitis, meibomitis, dry eyes, periocular skin changes and trichomegaly. EGFR inhibitors may also cause superficial punctate corneal changes and corneal erosions. Discussion: This is the first overview of all known ocular side effects associated with the use of marketed EGFR inhibitors. This is also the first effort for this class of drugs using the World Health Organization Classification as to causality. Conclusion: Ophthalmologists should be aware of possible adverse ocular side effects from EGFR inhibitors and treat based on the type of ADR encountered. All ocular side effects noted are fully reversible upon discontinuation of the drug.",
keywords = "Conjunctivitis, Dry eyes, Meibomitis, Toxicity, Trichomegaly",
author = "Fraunfelder, {Frederick (Fritz)} and Fraunfelder, {Frederick W.}",
year = "2012",
month = "9",
doi = "10.3109/15569527.2011.636118",
language = "English (US)",
volume = "31",
pages = "195--197",
journal = "Cutaneous and Ocular Toxicology",
issn = "1556-9527",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Trichomegaly and other external eye side effects associated with epidermal growth factor

AU - Fraunfelder, Frederick (Fritz)

AU - Fraunfelder, Frederick W.

PY - 2012/9

Y1 - 2012/9

N2 - Context/objective: To report an association between epithelial growth factor receptor (EGFR) inhibitors and ocular side effects. Materials and methods: Collection of spontaneous reports at the National Registry of Drug-Induced Ocular Side Effects (Casey Eye Institute, Portland, Oregon) in conjunction with a literature review of EGFR inhibitors associated with ocular adverse drug reactions (ADR). Results: EGFR inhibitors are associated with conjunctivitis, meibomitis, dry eyes, periocular skin changes and trichomegaly. EGFR inhibitors may also cause superficial punctate corneal changes and corneal erosions. Discussion: This is the first overview of all known ocular side effects associated with the use of marketed EGFR inhibitors. This is also the first effort for this class of drugs using the World Health Organization Classification as to causality. Conclusion: Ophthalmologists should be aware of possible adverse ocular side effects from EGFR inhibitors and treat based on the type of ADR encountered. All ocular side effects noted are fully reversible upon discontinuation of the drug.

AB - Context/objective: To report an association between epithelial growth factor receptor (EGFR) inhibitors and ocular side effects. Materials and methods: Collection of spontaneous reports at the National Registry of Drug-Induced Ocular Side Effects (Casey Eye Institute, Portland, Oregon) in conjunction with a literature review of EGFR inhibitors associated with ocular adverse drug reactions (ADR). Results: EGFR inhibitors are associated with conjunctivitis, meibomitis, dry eyes, periocular skin changes and trichomegaly. EGFR inhibitors may also cause superficial punctate corneal changes and corneal erosions. Discussion: This is the first overview of all known ocular side effects associated with the use of marketed EGFR inhibitors. This is also the first effort for this class of drugs using the World Health Organization Classification as to causality. Conclusion: Ophthalmologists should be aware of possible adverse ocular side effects from EGFR inhibitors and treat based on the type of ADR encountered. All ocular side effects noted are fully reversible upon discontinuation of the drug.

KW - Conjunctivitis

KW - Dry eyes

KW - Meibomitis

KW - Toxicity

KW - Trichomegaly

UR - http://www.scopus.com/inward/record.url?scp=84865339862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865339862&partnerID=8YFLogxK

U2 - 10.3109/15569527.2011.636118

DO - 10.3109/15569527.2011.636118

M3 - Article

C2 - 22122121

AN - SCOPUS:84865339862

VL - 31

SP - 195

EP - 197

JO - Cutaneous and Ocular Toxicology

JF - Cutaneous and Ocular Toxicology

SN - 1556-9527

IS - 3

ER -